Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Why Indegene’s BioPharm acquisition could become the blueprint for AI-first commercialization models in pharma Discover how Indegene’s $104 million acquisition of BioPharm is setting a new paradigm in AI-driven precision pharma marketing. byVenkateshOctober 8, 2025